Aura Biosciences (AURA) Prices 6.7M Shares at $12

Aura Biosciences, Inc. (Nasdaq: AURA) announced the pricing of an underwritten public offering of 6,700,000 shares of its common stock at a price to the public of $12.00 per share. The gross proceeds from the offering to Aura are expected to be $80.4 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about December 5, 2022, subject to customary closing conditions. In addition, Aura has granted the underwriters a 30-day option to purchase up to 1,005,000 additional shares of common stock at the public offering price, less the underwriting discount.

SVB Securities, Cowen and Evercore ISI are acting as joint bookrunning managers for the offering and JMP Securities, a Citizens Company, and BTIG are acting as co-managers for the offering.

You May Also Be Interested In

• ADARx Pharmaceuticals prices $446.3M IPO at $17 per share
• Bluerock Acquisition Corp. II prices $150M IPO on Nasdaq
• Carnival Corporation (CCL) PT Lowered to $32 at TD Cowen